PT MDS Retailing Tbk (ISX:LPPF) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:LPPF PT MDS Retailing Tbk ISX:LPPF
74 GF Score
Price Rp1,515.00
GF Value Rp1,340.88
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is PT MDS Retailing Tbk Research & Development?

PT MDS Retailing Tbk ISX:LPPF -0.33% 74 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:LPPF with a GF Score™ of 74/100 and a GF Value™ of Rp1,340.88 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT MDS Retailing Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT MDS Retailing Tbk  (ISX:LPPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT MDS Retailing Tbk Research & Development Related Terms

PT MDS Retailing Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT MDS Retailing Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT MDS Retailing Tbk Research & Development Chart

PT MDS Retailing Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT MDS Retailing Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:LPPF
74GF Score
PT MDS Retailing Tbk ISX:LPPF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT MDS Retailing Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT MDS Retailing Tbk (ISX:LPPF) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT MDS Retailing Tbk and its competitors.
Is PT MDS Retailing Tbk's Research & Development too high?
PT MDS Retailing Tbk's current Research & Development is Rp0 Mil. Overall, PT MDS Retailing Tbk has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT MDS Retailing Tbk's Research & Development compare to DDS and M?
PT MDS Retailing Tbk's Research & Development of Rp0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT MDS Retailing Tbk and its competitors. PT MDS Retailing Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT MDS Retailing Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT MDS Retailing Tbk (ISX:LPPF) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp1,340.88, compared to a current price of Rp1,515.00 — trading 13% above its estimated fair value. The current Research & Development is Rp0 Mil. PT MDS Retailing Tbk's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT MDS Retailing Tbk (ISX:LPPF), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT MDS Retailing Tbk (ISX:LPPF) Overvalued in 2026?

Based on GuruFocus' analysis, PT MDS Retailing Tbk stock appears to be overvalued. The current stock price of Rp1,515.00 is trading 13% above its estimated GF Value™ of Rp1,340.88. GuruFocus considers PT MDS Retailing Tbk to be Modestly Overvalued.

Key valuation signals for ISX:LPPF:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp1,340.88 vs. price of Rp1,515.00 (13% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the ISX:LPPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT MDS Retailing Tbk Business Description

Address Jalan Bulevar Palem Raya No. 7, Karawaci, Menara Matahari 12th Floor, Lippo Village, Tangerang, IDN, 15811
PT MDS Retailing Tbk is an Indonesia-based retail company that operates a national chain of department stores and online channels under the Matahari brand. Its portfolio also includes: SUKO, ZES, and MU+KU, and a portfolio of private label brands, including Nevada, COLE, Connexion, Little M, and others. These brands cover a range of apparel categories, from casual and family essentials to more fashion-forward and contemporary styles.
74GF Score

Get the complete analysis for ISX:LPPF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,515.00
Price
Rp1,340.88
GF Value